1-(4-Chlorophenyl)-1-(3-pyridinyl)methanamine(CAS: 883548-10-5)

Regulatory guidelines for 1-(4-Chlorophenyl)-1-(3-pyridinyl)methanamine (CAS: 883548-10-5) include GHS classification, REACH regulations, and FDA/EPA requirements. GHS classifies the compound as a hazardous substance due to its potential for skin and eye irritation. REACH regulations require manufacturers and importers to register the compound with the European Chemicals Agency (ECHA) if the annual tonnage exceeds 1 ton. FDA and EPA regulations may apply based on the intended use and potential environmental impact.

There are alternative reagents and molecules that can be used in synthesis as substitutes for 1-(4-Chlorophenyl)-1-(3-pyridinyl)methanamine (CAS: 883548-10-5). Common alternatives include 4-chloro-3-pyridinamine and related amine derivatives. These alternatives offer similar functional groups and can be used in analogous synthetic routes, providing researchers with options that may be safer or more environmentally friendly.

The market for 1-(4-Chlorophenyl)-1-(3-pyridinyl)methanamine (CAS: 883548-10-5) is driven by its applications in medicinal chemistry and pharmaceutical research. Recent trends indicate increased interest in the development of new antiviral and anti-inflammatory drugs. Research is focused on understanding its pharmacological properties and exploring its potential as a therapeutic agent. Market demand is expected to grow due to ongoing clinical trials and the expansion of drug discovery efforts.

Waste containing 1-(4-Chlorophenyl)-1-(3-pyridinyl)methanamine (CAS: 883548-10-5) should be collected in appropriate containers and stored in a secure, well-ventilated area. Incineration is a common method for disposal, but professional waste disposal services are recommended to ensure compliance with local regulations. Environmental protection measures include monitoring for hazardous emissions and using proper protective equipment. Always consult local waste management guidelines and disposal regulations for specific requirements.